Molecular characterization and pathogenesis of gastrointestinal stromal tumor.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Translational Gastroenterology and Hepatology

• Publication date

  2018-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.21037/tgh.2018.01.02PMID 29441367PMCID PMC5803009
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• EGFR gene mutation in gastrointestinal stromal tumours

  2017influential reference
• Clinicopathological and molecular features of a large cohort of gastrointestinal stromal tumors (GISTs) and review of the literature: BRAF mutations in KIT/PDGFRA wild-type GISTs are rare events.

  2017cited by this paper
• Microscopic gastrointestinal stromal tumours: a clinical and molecular study of 13 cases

  2017cited by this paper
• Genome-Wide Analysis Identifies MEN1 and MAX Mutations and a Neuroendocrine-Like Molecular Heterogeneity in Quadruple WT GIST

  2017cited by this paper
• The expression of hematopoietic progenitor cell antigen CD34 is regulated by DNA methylation in a site‐dependent manner in gastrointestinal stromal tumours

  2017cited by this paper
• MiRNA profiling of gastrointestinal stromal tumors by next-generation sequencing

  2017cited by this paper
• MAX inactivation is an early event in GIST development that regulates p16 and cell proliferation

  2017influential reference
• PARP2 controls double-strand break repair pathway choice by limiting 53BP1 accumulation at DNA damage sites and promoting end-resection

  2017cited by this paper
• Downregulation of miR-186 is associated with metastatic recurrence of gastrointestinal stromal tumors

  2017cited by this paper
• RAS Proteins and Their Regulators in Human Disease.

  2017cited by this paper
• FGFR1 and NTRK3 actionable alterations in “Wild-Type” gastrointestinal stromal tumors

  2016cited by this paper
• Promoter methylation of PCDH10 by HOTAIR regulates the progression of gastrointestinal stromal tumors

  2016cited by this paper
• Clinicopathological effects of protein phosphatase 2, regulatory subunit A, alpha mutations in gastrointestinal stromal tumors

  2016cited by this paper
• Long Noncoding RNAs in Cancer Pathways.

  2016cited by this paper
• A Screen for Epigenetically Silenced microRNA Genes in Gastrointestinal Stromal Tumors

  2015cited by this paper
• Combined inhibition of MAP kinase and KIT signaling synergistically destabilizes ETV1 and suppresses GIST tumor growth.

  2015cited by this paper
• The landscape of long noncoding RNAs in the human transcriptome

  2015cited by this paper
• BRCA 1/2 gene mutation and gastrointestinal stromal tumours: a potential association

  2015cited by this paper
• LncRNA HOTAIR: A master regulator of chromatin dynamics and cancer.

  2015cited by this paper
• SETD2 histone modifier loss in aggressive GI stromal tumours

  2015cited by this paper
• KIT, PDGFRA, and BRAF Mutational Spectrum Impacts on the Natural History of Imatinib-naive Localized GIST: A Population-based Study

  2015influential reference
• microRNA-218 increase the sensitivity of gastrointestinal stromal tumor to imatinib through PI3K/AKT pathway

  2015cited by this paper
• Platelet-Derived Growth Factor Receptor-α Regulates Proliferation of Gastrointestinal Stromal Tumor Cells With Mutations in KIT by Stabilizing ETV1.

  2015cited by this paper
• Genome-wide functional screening identifies CDC37 as a crucial HSP90-cofactor for KIT oncogenic expression in gastrointestinal stromal tumors

  2014cited by this paper
• Integrated genomic study of quadruple-WT GIST (KIT/PDGFRA/SDH/RAS pathway wild-type GIST)

  2014cited by this paper
• Abstract 1572: Dystrophin Is a tumor suppressor in human cancers with myogenic programs

  2014cited by this paper
• Tumor Genotype Is an Independent Prognostic Factor in Primary Gastrointestinal Stromal Tumors of Gastric Origin: A European Multicenter Analysis Based on ConticaGIST

  2014influential reference
• Frequent KIT Mutations in Human Gastrointestinal Stromal Tumors

  2014cited by this paper
• Gastrointestinal stromal tumors with exon 8 c-kit gene mutation might occur at extragastric sites and have metastasis-prone nature.

  2014cited by this paper
• microRNA expression signatures of gastrointestinal stromal tumours: associations with imatinib resistance and patient outcome

  2014cited by this paper
• The long non-coding RNA HOTAIR indicates a poor prognosis and promotes metastasis in non-small cell lung cancer

  2013cited by this paper
• Immunohistochemical Loss of Succinate Dehydrogenase Subunit A (SDHA) in Gastrointestinal Stromal Tumors (GISTs) Signals SDHA Germline Mutation

  2013cited by this paper
• Germline SDHC mutation presenting as recurrent SDH deficient GIST and renal carcinoma.

  2013cited by this paper
• MiR-17-92 and miR-221/222 cluster members target KIT and ETV1 in human gastrointestinal stromal tumours

  2013influential reference
• Expression of the Receptor for Type I Insulin-like Growth Factor (IGF1R) in Gastrointestinal Stromal Tumors: An Immunohistochemical Study of 1078 Cases With Diagnostic and Therapeutic Implications

  2013influential reference
• Succinate dehydrogenase mutation underlies global epigenomic divergence in gastrointestinal stromal tumor.

  2013cited by this paper
• A subset of gastrointestinal stromal tumors previously regarded as wild-type tumors carries somatic activating mutations in KIT exon 8 (p.D419del)

  2013cited by this paper
• Long non-coding RNA HOTAIR is an independent prognostic marker of metastasis in estrogen receptor-positive primary breast cancer

  2013cited by this paper
• Loss of SDHA Expression Identifies SDHA Mutations in Succinate Dehydrogenase–deficient Gastrointestinal Stromal Tumors

  2013cited by this paper
• Succinate dehydrogenase deficiency is associated with decreased 5-hydroxymethylcytosine production in gastrointestinal stromal tumors: implications for mechanisms of tumorigenesis

  2013cited by this paper
• Fascin-1 overexpression and miR-133b downregulation in the progression of gastrointestinal stromal tumor

  2013cited by this paper
• Overexpression of insulin‐like growth factor 1 receptor and frequent mutational inactivation of SDHA in wild‐type SDHB‐negative gastrointestinal stromal tumors

  2013cited by this paper
• Secondary mutations of c-KIT contribute to acquired resistance to imatinib and decrease efficacy of sunitinib in Chinese patients with gastrointestinal stromal tumors

  2013cited by this paper
• KRAS and BRAF Mutations Predict Primary Resistance to Imatinib in Gastrointestinal Stromal Tumors

  2012cited by this paper
• ENDOGLIN/CD105 is expressed in KIT positive cells in the gut and in gastrointestinal stromal tumours

  2012cited by this paper
• Prognostic value of KIT/PDGFRA mutations in gastrointestinal stromal tumours (GIST): Polish Clinical GIST Registry experience.

  2012influential reference
• Upregulation of miR-196a and HOTAIR drive malignant character in gastrointestinal stromal tumors.

  2012cited by this paper
• p53 Modulation as a Therapeutic Strategy in Gastrointestinal Stromal Tumors

  2012cited by this paper
• Long‐term exposure of gastrointestinal stromal tumor cells to sunitinib induces epigenetic silencing of the PTEN gene

  2012cited by this paper
• Succinate dehydrogenase-deficient GISTs are characterized by IGF1R overexpression

  2012influential reference
• Succinate dehydrogenase (SDH) and mitochondrial driven neoplasia

  2012cited by this paper
• Down-regulation of miR-221 and miR-222 correlates with pronounced Kit expression in gastrointestinal stromal tumors.

  2011cited by this paper
• MicroRNA-494 Downregulates KIT and Inhibits Gastrointestinal Stromal Tumor Cell Proliferation

  2011cited by this paper
• SDHB immunohistochemistry: a useful tool in the diagnosis of Carney–Stratakis and Carney triad gastrointestinal stromal tumors

  2011cited by this paper
• Expression profile of the N-myc Downstream Regulated Gene 2 (NDRG2) in human cancers with focus on breast cancer

  2011cited by this paper
• Histopathology of gastrointestinal stromal tumor

  2011cited by this paper
• Spectrum of KIT/PDGFRA/BRAF mutations and Phosphatidylinositol-3-Kinase pathway gene alterations in gastrointestinal stromal tumors (GIST).

  2011influential reference
• Role for p16(INK4a) in progression of gastrointestinal stromal tumors of the stomach: alteration of p16(INK4a) network members.

  2011cited by this paper
• Aberrant DNA methylation associated with aggressiveness of gastrointestinal stromal tumour

  2011cited by this paper
• A Novel Correlation between LINE-1 Hypomethylation and the Malignancy of Gastrointestinal Stromal Tumors

  2010cited by this paper
• Localization‐ and mutation‐dependent microRNA (miRNA) expression signatures in gastrointestinal stromal tumours (GISTs), with a cluster of co‐expressed miRNAs located at 14q32.31

  2010cited by this paper
• Prognostic time dependence of deletions affecting codons 557 and/or 558 of KIT gene for relapse-free survival (RFS) in localized GIST: a Spanish Group for Sarcoma Research (GEIS) Study.

  2010cited by this paper
• MicroRNA expression profile of gastrointestinal stromal tumors is distinguished by 14q loss and anatomic site

  2010cited by this paper
• BRAF mutation status in gastrointestinal stromal tumors.

  2010influential reference
• ETV1 is a lineage survival factor that cooperates with KIT in gastrointestinal stromal tumours

  2010cited by this paper
• Gastric Stromal Tumors in Carney Triad Are Different Clinically, Pathologically, and Behaviorally From Sporadic Gastric Gastrointestinal Stromal Tumors: Findings in 104 Cases

  2010cited by this paper
• Succinate dehydrogenase - Assembly, regulation and role in human disease.

  2010cited by this paper
• DOG1 Antibody in the Differential Diagnosis of Gastrointestinal Stromal Tumors: A Study of 1840 Cases

  2009cited by this paper
• KIT kinase mutants show unique mechanisms of drug resistance to imatinib and sunitinib in gastrointestinal stromal tumor patients

  2009cited by this paper
• NDRG2 expression decreases with tumor stages and regulates TCF/β-catenin signaling in human colon carcinoma

  2009cited by this paper
• V600E BRAF mutations are alternative early molecular events in a subset of KIT/PDGFRA wild-type gastrointestinal stromal tumours

  2009cited by this paper
• Insulin-like growth factor 1 receptor is a potential therapeutic target for gastrointestinal stromal tumors

  2008influential reference
• B-Raf(V600E) cooperates with alternative spliced Rac1b to sustain colorectal cancer cell survival.

  2008cited by this paper
• Akt3 and mutant V600E B-Raf cooperate to promote early melanoma development.

  2008cited by this paper
• Clinicopathologic profile of gastrointestinal stromal tumors (GISTs) with primary KIT exon 13 or exon 17 mutations: a multicenter study on 54 cases

  2008cited by this paper
• Secondary mutations in the kinase domain of the KIT gene are predominant in imatinib‐resistant gastrointestinal stromal tumor

  2008cited by this paper
• Aberrant methylation status of known methylation‐sensitive CpG islands in gastrointestinal stromal tumors without any correlation to the state of c‐kit and PDGFRA gene mutations and their malignancy

  2008cited by this paper
• In Vitro and In Vivo Analysis of B-Myb in Basal-Like Breast Cancer

  2008cited by this paper
• A Novel Monoclonal Antibody Against DOG1 is a Sensitive and Specific Marker for Gastrointestinal Stromal Tumors

  2008cited by this paper
• An oncogenetic tree model in gastrointestinal stromal tumours (GISTs) identifies different pathways of cytogenetic evolution with prognostic implications

  2007influential reference
• Mutations in gastrointestinal stromal tumors – a population‐based study from Northern Norway

  2007cited by this paper
• Dynamic histone H3 methylation during gene induction: HYPB/Setd2 mediates all H3K36 trimethylation

  2007cited by this paper
• Array comparative genomic hybridization analysis of chromosomal imbalances and their target genes in gastrointestinal stromal tumors

  2007cited by this paper
• Merlin/neurofibromatosis type 2 suppresses growth by inhibiting the activation of Ras and Rac.

  2007cited by this paper
• The Platelet-derived Growth Factor Receptor α Is Destabilized by Geldanamycins in Cancer Cells*

  2007cited by this paper
• Promoter methylation, mutation, and genomic deletion are involved in the decreased NDRG2 expression levels in several cancer cell lines.

  2007cited by this paper
• The platelet-derived growth factor receptor alpha is destabilized by geldanamycins in cancer cells.

  2007cited by this paper
• A brake becomes an accelerator: PTP1B--a new therapeutic target for breast cancer.

  2007cited by this paper
• Array CGH analysis in primary gastrointestinal stromal tumors: Cytogenetic profile correlates with anatomic site and tumor aggressiveness, irrespective of mutational status

  2007cited by this paper
• Minute Gastric Sclerosing Stromal Tumors (GIST Tumorlets) Are Common in Adults and Frequently Show c-KIT Mutations

  2007cited by this paper
• KRAS and BRAF oncogenic mutations in MSS colorectal carcinoma progression

  2007cited by this paper
• GISTs with PDGFRA exon 14 mutations represent subset of clinically favorable gastric tumors with epithelioid morphology

  2006cited by this paper
• Molecular pathogenesis of multiple gastrointestinal stromal tumors in NF1 patients.

  2006cited by this paper
• KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours.

  2006cited by this paper
• High incidence of microscopic gastrointestinal stromal tumors in the stomach.

  2006cited by this paper
• Gastrointestinal Stromal Tumors in Patients With Neurofibromatosis 1: A Clinicopathologic and Molecular Genetic Study of 45 Cases

  2006cited by this paper
• Heat shock protein 90 inhibition in imatinib-resistant gastrointestinal stromal tumor.

  2006cited by this paper
• A new familial GIST identified.

  2006cited by this paper
• Oncogenic Kit signaling and therapeutic intervention in a mouse model of gastrointestinal stromal tumor

  2006cited by this paper
• PDGFRA mutations in gastrointestinal stromal tumors: frequency, spectrum and in vitro sensitivity to imatinib.

  2005cited by this paper

• A Rare Case of Massive Gastrointestinal Hemorrhage Caused by an Ileal Gastrointestinal Stromal Tumor

  2025cites this paper
• Multifocal Gastrointestinal Stromal Tumors (GISTs) of the Small Intestine in Patients with Neurofibromatosis Type 1 (NF-1): Meta-Analysis and Systematic Review of the Literature

  2025cites this paper
• Nuclear Pleomorphism in Gastrointestinal Stromal Tumors: Insights Beyond Risk Stratification

  2025influential citation
• Iodothyronine Deiodinase 3 Gene Expression in Gastrointestinal Stromal Tumors: A Pilot Study to Contribute to Risk Assessment

  2024cites this paper
• Arbutus unedo L. Fractions Exhibit Chemotherapeutic Properties for the Treatment of Gastrointestinal Stromal Tumors

  2024cites this paper
• Exploring Perforated Jejunal GIST: A Rare Case Report and Review of Molecular and Clinical Literature

  2024influential citation
• Genomic profiling in GIST: Implications in clinical outcome and future challenges

  2024influential citation
• Exploring nanotechnology solutions for improved outcomes in gastrointestinal stromal tumors

  2024cites this paper
• Roles of PDGF/PDGFR signaling in various organs

  2024cites this paper
• Gastrointestinal Stromal Tumors (GISTs) in Pediatric Patients: A Case Report and Literature Review

  2024cites this paper
• Gene Mutations in Gastrointestinal Stromal Tumors: Advances in Treatment and Mechanism Research

  2024cites this paper
• Genomic and clinical characterization of a familial GIST kindred intolerant to imatinib

  2024cites this paper
• Molecular features of gastrointestinal stromal tumors “wild-type” (KIT/PDGFRA WT)

  2023cites this paper
• Immunotherapy of gastrointestinal stromal tumors: current view and future directions

  2023cites this paper
• c-Kit Receptors as a Therapeutic Target in Cancer: Current Insights

  2023cites this paper
• The multifaceted landscape behind imatinib resistance in gastrointestinal stromal tumors (GISTs): A lesson from ripretinib.

  2023cites this paper
• Mesenchymal stromal cells promote the drug resistance of gastrointestinal stromal tumors by activating the PI3K-AKT pathway via TGF-β2

  2023cites this paper
• Advances in Molecular Studies of Gastrointestinal Stromal Tumors

  2022cites this paper
• Clinical and Molecular Characteristics of Rare Malignant Tumors of Colon and Rectum

  2022influential citation
• Inhibition of PI3K and MAPK pathways along with KIT inhibitors as a strategy to overcome drug resistance in gastrointestinal stromal tumors

  2021cites this paper
• Gastrointestinal, Hepatobiliary, and Pancreatic Tumors

  2021cites this paper
• Gastrointestinal stromal tumor: a review of current and emerging therapies

  2021cites this paper
• Caveolin-1 expression predicts favourable outcome and correlates with PDGFRA mutations in gastrointestinal stromal tumours (GISTs)

  2021cites this paper
• Second-line sunitinib for Chinese patients with advanced gastrointestinal stromal tumor: 37.5 mg schedule outperformed 50 mg schedule in adherence and prognosis

  2021cites this paper
• Prevalence and significance of M541L single nucleotide polymorphism in the central European cohort of gastrointestinal stromal tumor patients

  2020influential citation
• Low Frequency of Mutation Testing in the United States

  2020cites this paper
• CASE 18F-FDG PET/CT “hepatic superscan” in incomplete Carney triad

  2020cites this paper
• Spectrum of activity of dasatinib against mutant KIT kinases associated with drug-sensitive and drug-resistant gastrointestinal stromal tumors

  2020cites this paper
• A mutation-specific, single-arm, phase 2 study of dovitinib in patients with advanced malignancies

  2020cites this paper
• Secondary Resistant Mutations to Small Molecule Inhibitors in Cancer Cells

  2020cites this paper
• Endoscopic ultrasound-guided fine-needle aspiration cytology in the diagnosis of the gastrointestinal stromal tumor of the stomach.

  2020cites this paper
• Surgical Oncology Manual

  2020cites this paper
• Feedback of extended panel sequencing in 1530 patients referred for suspicion of hereditary predisposition to adult cancers

  2020cites this paper
• Oncogene mutational analysis in imatinib naive population of gastrointestinal stromal tumor patients

  2020influential citation
• Gastrointestinal Stromal Tumors—A Case Report With Review and Discussion of Updates

  2019cites this paper
• Gastrointestinal Stromal Tumor

  2019cites this paper
• KIT Mutation Incidence and Pattern of Melanoma in Central Europe

  2019cites this paper
• Hedgehog signalling pathway activation in gastrointestinal stromal tumours is mediated by primary cilia

  2019cites this paper
• Targeting the WEE1 kinase strengthens the antitumor activity of imatinib via promoting KIT autophagic degradation in gastrointestinal stromal tumors

  2019cites this paper
• When Phenotype Does Not Match Genotype-The Importance of Returning to the Raw Data.

  2019cites this paper
• Cancer Treatment in the Genomic Era.

  2019cites this paper
• Recently Discovered Interstitial Cell Population of Telocytes: Distinguishing Facts from Fiction Regarding Their Role in the Pathogenesis of Diverse Diseases Called “Telocytopathies”

  2019cites this paper
• Dedifferentiated gastrointestinal stromal tumor: Recent advances.

  2019cites this paper
• Laparoscopic Endoscopic Cooperative Surgery for Gastrointestinal Stromal Tumors.

  2018cites this paper
• Histone demethylase KDM4D promotes gastrointestinal stromal tumor progression through HIF1β/VEGFA signalling

  2018cites this paper